Immunic Q2 EPS $(0.20) Misses $(0.17) Estimate
Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.17) by 15.61 percent. This is a 4.76 percent increase over losses of $(0.21) per share from the same
